Q1FY23 Preview: Apollo Hospitals: Revenue seen at Rs37,400 million; PAT at Rs1,500 million

10 Aug 2022 , 03:01 PM

Result date: 11th August
Recommendation: Buy
Target price: Rs4,850

Apollo Hospitals is likely to witness improvement in occupancy of non-COVID patients in the June quarter. Pharmacy business could post flattish growth in the quarter. Revenue could dip 0.5% over the year-ago quarter. This decline is because of the high base effect of June quarter of the previous year. EBITDA could decline 8.05%, on the back of a high base.

Profit After Tax (PAT) could fall 47.53% over the year-ago quarter, owing to lower other income. 

Key management insights to look into:

• Growth outlook for key business segments
• Traction of Apollo 24/7
• Improvement in international patients segment in the hospitals business

Rs. Million	June 2022 estimates	Y-o-Y
Revenue	37,400	(0.5%)
EBITDA	4,780	(8.05%)
PAT	1,500	(47.53%)

Source: Brokerage Reports